cholinesterase inhibitor
Showing 1 - 25 of 7,466
Cognitive Impairment, Elderly Trial in Portland (2g Centella asiatica water extract product, 4g Centella asiatica water extract
Terminated
- Cognitive Impairment
- Elderly
- 2g Centella asiatica water extract product
- 4g Centella asiatica water extract product
-
Portland, OregonOregon Health and Science University Department of Neurology
Apr 8, 2022
Dementia Trial in United States (Cholinesterase inhibitor, Sham discontinuation)
Completed
- Dementia
- Cholinesterase inhibitor
- Sham discontinuation
-
Little Rock, Arkansas
- +3 more
Sep 29, 2020
Parkinson Disease Trial in United Kingdom (Rivastigmine Transdermal System, Placebo Transdermal System)
Recruiting
- Parkinson Disease
- Rivastigmine Transdermal System
- Placebo Transdermal System
-
Romford, Accepted, United Kingdom
- +26 more
Dec 22, 2021
Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)
Not yet recruiting
- Alzheimer Disease
- Placebo
- +2 more
-
Paris, FranceInstitut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022
Genetic Risk for Alzheimer's Disease Trial in Cleveland (donepezil HCL, Placebo)
Active, not recruiting
- Genetic Risk for Alzheimer's Disease
- donepezil HCL
- Placebo
-
Cleveland, OhioCleveland Clinic Center for Brain Health
May 16, 2022
Predicting Delirium by Attentional Dysfunction
Completed
- Delirium in Old Age
- The Cholinesterase Inhibitor Prognosticator (ChIP) application for iPad
- (no location specified)
Jun 12, 2019
Alzheimer, Mild Cognitive Impairment Trial in Boca Raton, New York, Madison (Placebo, Eligard 22.5Mg Suspension for Injection)
Recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- Placebo
- Eligard 22.5Mg Suspension for Injection
-
Boca Raton, Florida
- +2 more
Jan 24, 2023
Alzheimer Trial in Worldwide (lecozotan SR (SRA-333))
Completed
- Alzheimer Disease
- lecozotan SR (SRA-333)
-
Phoenix, Arizona
- +82 more
Jul 1, 2020
Healthy Volunteers Trial in Baltimore (BNC, Placebo)
Completed
- Healthy Volunteers
- BNC
- Placebo
-
Baltimore, MarylandNational Institute on Aging, Clinical Research Unit
Feb 2, 2023
Depressive Disorder Trial in Utrecht (Rivastigmine Transdermal Product, Sham)
Recruiting
- Depressive Disorder
- Rivastigmine Transdermal Product
- Sham
-
Utrecht, NetherlandsUMC Utrecht
Mar 2, 2023
Alzheimer Trial in Korea, Republic of (Choline Alfoscerate 400mg, Placebo)
Recruiting
- Alzheimer Disease
- Choline Alfoscerate 400mg
- Placebo
-
Changwon, Korea, Republic of
- +3 more
May 16, 2022
Bilateral Sensorineural Hearing Loss Trial (Donepezil, Placebo)
Not yet recruiting
- Bilateral Sensorineural Hearing Loss
- Donepezil
- Placebo
- (no location specified)
Jul 7, 2022
Postoperative Vomiting, Postoperative Nausea, Postoperative Delirium Trial in Istanbul (Group N; neostigmine+atropine, GROUP S;
Active, not recruiting
- Postoperative Vomiting
- +2 more
- Group N; neostigmine+atropine
- GROUP S; decurarized with sugammadex.
-
Istanbul, Maltepe, TurkeyMarmara University
Nov 8, 2022
Parkinson Disease, Parkinson Disease Dementia Trial in Baltimore (Rivastigmine transdermal patch)
Completed
- Parkinson Disease
- Parkinson Disease Dementia
- Rivastigmine transdermal patch
-
Baltimore, MarylandUniversity of Maryland School of Medicine, Dept. of Neurology
Jan 25, 2022
Total Knee Arthroplasty, Fracture of Head of Femur Articular Displaced, Protrusion of Intervertebral Disc Trial in Shanghai
Recruiting
- Total Knee Arthroplasty
- +2 more
- Donepezil
- Placebo
-
Shanghai, Shanghai, ChinaRenji Hospital
Dec 28, 2020
Chinese Herbal Medicine in Alzheimer's Disease
Completed
- Alzheimer Disease
- GRAPE granules
-
Beijing, ChinaDongzhimen Hospital
Aug 18, 2021
Hallucinations, Auditory, Psychosis Trial in New Haven (Rivastigmine Transdermal Product, Scopolamine, Placebo)
Recruiting
- Hallucinations, Auditory
- Psychosis
- Rivastigmine Transdermal Product
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Mar 2, 2022
Postdural Puncture Headache Trial (Pyridostigmine, Placebo)
Not yet recruiting
- Postdural Puncture Headache
- Pyridostigmine
- Placebo
- (no location specified)
Jul 29, 2023
Presbycusis, Tinnitus, Cognitive Impairment Trial in Shanghai (BTHE and Huperzine A, BETH)
Enrolling by invitation
- Presbycusis
- +2 more
- BTHE and Huperzine A
- BETH
-
Shanghai, Shanghai, ChinaHuadong Hospital
Mar 16, 2022
Parkinson's Disease Trial in Portland (Donepezil, Placebo)
Completed
- Parkinson's Disease
- Donepezil
- Placebo
-
Portland, OregonParkinson's Center of Oregon - Oregon Health and Science Univers
Sep 9, 2021
Organophosphate Poisoning Trial (Serum Pararoxonase -1 level, Diagnostic Test: Serum pseudocholinesterase enzyme level)
Not yet recruiting
- Organophosphate Poisoning
- Serum Pararoxonase -1 level
- Diagnostic Test: Serum pseudocholinesterase enzyme level
- (no location specified)
Oct 25, 2023
Functional Dyspepsia, Postprandial Fullness Syndrome Trial (Itopride, Placebo)
Completed
- Functional Dyspepsia
- Postprandial Fullness Syndrome
- Itopride
- Placebo
- (no location specified)
Nov 23, 2020
Observational Study in Bariatric Surgery
Recruiting
- Obesity
- +2 more
- NO INTERVENTION, it is an observational study
-
Poitiers, FranceCHU de Poitiers
Jun 10, 2022